Biotechnology Assets SA
MAD:BST

Watchlist Manager
Biotechnology Assets SA Logo
Biotechnology Assets SA
MAD:BST
Watchlist
Price: 0.29 EUR -0.68% Market Closed
Market Cap: 18.9m EUR
Have any thoughts about
Biotechnology Assets SA?
Write Note

Biotechnology Assets SA
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Biotechnology Assets SA
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Biotechnology Assets SA
MAD:BST
Revenue
€3.1m
CAGR 3-Years
2%
CAGR 5-Years
-39%
CAGR 10-Years
N/A
Grifols SA
MAD:GRF
Revenue
€6.6B
CAGR 3-Years
7%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Oryzon Genomics SA
MAD:ORY
Revenue
€0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pharma Mar SA
MAD:PHM
Revenue
€167m
CAGR 3-Years
-4%
CAGR 5-Years
15%
CAGR 10-Years
1%
No Stocks Found

Biotechnology Assets SA
Glance View

Market Cap
18.5m EUR
Industry
Biotechnology

Biotechnology Assets SA operates as a biopharmaceutical company. The company is headquartered in Jerez De La Frontera, Cadiz and currently employs 32 full-time employees. The company went IPO on 2011-06-14. The Firm’s main activities are: Research, development and production of biotechnological solutions aimed at improving the health and welfare of people and animals; Development, acquisition, transfer and exploitation of industrial and intellectual property rights; Distribution, marketing, export and import of the previously mentioned products. The Company, through its subsidiaries, is also present in Luxembourg, Hong Kong and USA.

BST Intrinsic Value
0.29 EUR
Overvaluation 1%
Intrinsic Value
Price

See Also

What is Biotechnology Assets SA's Revenue?
Revenue
3.1m EUR

Based on the financial report for Jun 30, 2024, Biotechnology Assets SA's Revenue amounts to 3.1m EUR.

What is Biotechnology Assets SA's Revenue growth rate?
Revenue CAGR 5Y
-39%

Over the last year, the Revenue growth was -4%. The average annual Revenue growth rates for Biotechnology Assets SA have been 2% over the past three years , -39% over the past five years .

Back to Top